Rebecca Louise Davie,Hannah Joy Edwards,David Michael Evans,Simon Teanby Hodgson
申请号：
US16438061
公开号：
US20190300517A1
申请日:
2019.06.11
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides compounds of formula (I):compositions comprising such compounds； the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated)； and methods of treating patients with such compounds； wherein R5, R6, R7, A, B, W, X, Y and Z are as defined herein.
